Author Archives: Sara Agee Le

July 23, 2019
In The News

Noah Miller of Newsweek interviews Abraham Heifets, Atomwise CEO, about his Moonshot.

Read Article
July 10, 2019
Press Release

Ann Arbor, Michigan – From making pain management safer and more effective to identifying inhibitors for a fibrosis target protein and more, researchers from Michigan Medicine, as well as the University of Michigan College of Pharmacy and U-M Life Sciences Institute, are looking to advance their projects through Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards […]

Read Article
June 26, 2019
In The News

Conor Hale of FierceBiotech reports on the launch of Atomwise’s 10-to-the-10 program.

Read Article
June 23, 2019
Press Release

Atomwise, Enamine, and top university researchers collaborate to discover novel small molecules for the treatment of pediatric cancers using the power of AI and novel chemistry. SAN FRANCISCO, Calif., and KIEV, Ukraine, June 24, 2019 – Atomwise, Inc. today announced the launch of a 10 billion compound AI-powered virtual drug screening initiative, the 10-to-the-10 program, […]

Read Article
June 5, 2019
In The News

Genetic Engineering & Biotechnology News (GEN) report on the recent announcement of Eli Lilly’s partnership with Atomwise.

Read Article
June 4, 2019
In The News

Having signed a multi-year, multi-target agreement with Lilly worth potentially $550m, Atomwise CEO Abe Heifets tells Scrip the burden of proof is on AI practitioners to start producing relevant and actionable data.

Read Article